Literature DB >> 19149790

Added value of a resting ECG neural network that predicts cardiovascular mortality.

Marco V Perez1, Frederick E Dewey, Swee Y Tan, Jonathan Myers, Victor F Froelicher.   

Abstract

BACKGROUND: The resting 12-lead electrocardiogram (ECG) remains the most commonly used test in evaluating patients with suspected cardiovascular disease. Prognostic values of individual findings on the ECG have been reported but may be of limited use.
METHODS: The characteristics of 45,855 ECGs ordered by physician's discretion were first recorded and analyzed using a computerized system. Ninety percent of these ECGs were used to train an artifical neural network (ANN) to predict cardiovascular mortality (CVM) based on 132 ECG and four demographic characteristics. The ANN generated a Resting ECG Neural Network (RENN) score that was then tested in the remaining ECGs. The RENN score was finally assessed in a cohort of 2189 patients who underwent exercise treadmill testing and were followed for CVM.
RESULTS: The RENN score was able to better predict CVM compared to individual ECG markers or a traditional Cox regression model in the testing cohort. Over a mean of 8.6 years, there were 156 cardiovascular deaths in the treadmill cohort. Among the patients who were classified as intermediate risk by Duke Treadmill Scoring (DTS), the third tertile of the RENN score demonstrated an adjusted Cox hazard ratio of 5.4 (95% CI 2.0-15.2) compared to the first RENN tertile. The 10-year CVM was 2.8%, 8.6% and 22% in the first, second and third RENN tertiles, respectively.
CONCLUSIONS: An ANN that uses the resting ECG and demographic variables to predict CVM was created. The RENN score can further risk stratify patients deemed at moderate risk on exercise treadmill testing.

Entities:  

Mesh:

Year:  2009        PMID: 19149790      PMCID: PMC6932462          DOI: 10.1111/j.1542-474X.2008.00270.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  35 in total

1.  Comparison of the ramp versus standard exercise protocols.

Authors:  J Myers; N Buchanan; D Walsh; M Kraemer; P McAuley; M Hamilton-Wessler; V F Froelicher
Journal:  J Am Coll Cardiol       Date:  1991-05       Impact factor: 24.094

2.  A neural computational aid to the diagnosis of acute myocardial infarction.

Authors:  William G Baxt; Frances S Shofer; Frank D Sites; Judd E Hollander
Journal:  Ann Emerg Med       Date:  2002-04       Impact factor: 5.721

3.  Prognostic Significance of Quantitative QRS Duration.

Authors:  Aseem D Desai; Tan Swee Yaw; Takuya Yamazaki; Amir Kaykha; Sung Chun; Victor F Froelicher
Journal:  Am J Med       Date:  2006-07       Impact factor: 4.965

4.  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention.

Authors:  R Cooper; J Cutler; P Desvigne-Nickens; S P Fortmann; L Friedman; R Havlik; G Hogelin; J Marler; P McGovern; G Morosco; L Mosca; T Pearson; J Stamler; D Stryer; T Thom
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

5.  Acute pulmonary embolism: artificial neural network approach for diagnosis.

Authors:  G D Tourassi; C E Floyd; H D Sostman; R E Coleman
Journal:  Radiology       Date:  1993-11       Impact factor: 11.105

6.  Use of an artificial neural network for the diagnosis of myocardial infarction.

Authors:  W G Baxt
Journal:  Ann Intern Med       Date:  1991-12-01       Impact factor: 25.391

7.  Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease.

Authors:  D B Mark; L Shaw; F E Harrell; M A Hlatky; K L Lee; J R Bengtson; C B McCants; R M Califf; D B Pryor
Journal:  N Engl J Med       Date:  1991-09-19       Impact factor: 91.245

8.  Detecting acute myocardial infarction in the 12-lead ECG using Hermite expansions and neural networks.

Authors:  Henrik Haraldsson; Lars Edenbrandt; Mattias Ohlsson
Journal:  Artif Intell Med       Date:  2004-10       Impact factor: 5.326

9.  A QRS scoring system for assessing left ventricular function after myocardial infarction.

Authors:  S T Palmeri; D G Harrison; F R Cobb; K G Morris; F E Harrell; R E Ideker; R H Selvester; G S Wagner
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

10.  Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States.

Authors:  Ahmet Ergin; Paul Muntner; Roger Sherwin; Jiang He
Journal:  Am J Med       Date:  2004-08-15       Impact factor: 4.965

View more
  5 in total

Review 1.  The year of 2009 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

2.  High-risk electrocardiographic parameters are ubiquitous in patients with ischemic cardiomyopathy.

Authors:  Mary G Carey; Salah S Al-Zaiti; John M Canty; James A Fallavollita
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

Review 3.  Artificial Intelligence and Machine Learning in Arrhythmias and Cardiac Electrophysiology.

Authors:  Albert K Feeny; Mina K Chung; Anant Madabhushi; Zachi I Attia; Maja Cikes; Marjan Firouznia; Paul A Friedman; Matthew M Kalscheur; Suraj Kapa; Sanjiv M Narayan; Peter A Noseworthy; Rod S Passman; Marco V Perez; Nicholas S Peters; Jonathan P Piccini; Khaldoun G Tarakji; Suma A Thomas; Natalia A Trayanova; Mintu P Turakhia; Paul J Wang
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-07-06

Review 4.  Machine Learning in Arrhythmia and Electrophysiology.

Authors:  Natalia A Trayanova; Dan M Popescu; Julie K Shade
Journal:  Circ Res       Date:  2021-02-18       Impact factor: 17.367

5.  Assessment of electrocardiogram abnormality and associated factors among apparently healthy adult type 2 diabetic patients on follow-up at Jimma Medical Center, Southwest Ethiopia: Cross-sectional study.

Authors:  Deriba A Bedane; Samuel Tadesse; Moyeta Bariso; Wondu Reta; Gaddisa Desu
Journal:  BMC Cardiovasc Disord       Date:  2021-06-24       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.